Cerevel Therapeutics Holdings Inc

NASDAQ:CERE  
42.21
+0.07 (+0.17%)
7:58:43 PM EDT: $42.30 +0.09 (+0.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cerevel Therapeutics Holdings Inc Stock, NASDAQ:CERE

222 Jacobs Street, Suite 200, Cambridge, Massachusetts 02141
United States of America
Phone: +1.844.304.2048
Number of Employees: 334
http://www.cerevel.com

Description

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.